Low serum creatinine is associated with type 2 diabetes in morbidly obese women and men: a cross-sectional study
Tóm tắt
Low skeletal muscle mass is associated with insulin resistance and metabolic syndrome. Serum creatinine may serve as a surrogate marker of muscle mass, and a possible relationship between low serum creatinine and type 2 diabetes has recently been demonstrated. We aimed to validate this finding in a population of Caucasian morbidly obese subjects. Cross-sectional study of 1,017 consecutive morbidly obese patients with an estimated glomerular filtration rate >60 ml/min/1.73 m2. Logistic regression (univariate and multiple) was used to assess the association between serum creatinine and prevalent type 2 diabetes, including statistically testing for the possibility of non-linearity in the relationship by implementation of Generalized Additive Models (GAM) and piecewise linear regression. Possible confounding variables such as age, family history of diabetes, waist-to-hip ratio, hypertension, current smoking, serum magnesium, albuminuria and insulin resistance (log HOMA-IR) were adjusted for in three separate multiple logistic regression models. The unadjusted GAM analysis suggested a piecewise linear relationship between serum creatinine and diabetes. Each 1 μmol/l increase in serum creatinine was associated with 6% (95% CI; 3%-8%) and 7% (95% CI; 2%-13%) lower odds of diabetes below serum creatinine levels of 69 and 72 μmol/l in women and men, respectively. Above these breakpoints the serum creatinine concentrations did not reduce the odds further. Adjustments for non-modifiable and modifiable risk factors left the piecewise effect for both women and men largely unchanged. In the fully adjusted model, which includes serum magnesium, albuminuria and log HOMA-IR, the piecewise effect for men was statistically non-significant, but it remained present for women. Patients with creatinine levels below median had approximately 50% (women) and 75% (men) increased odds of diabetes. Low serum creatinine is a predictor of type 2 diabetes in Caucasian morbidly obese patients, independent of age, gender, family history of diabetes, anthropometric measures, hypertension, and current smoking. Longitudinal studies of both obese and non-obese populations are needed to investigate whether serum creatinine may be causally linked with type 2 diabetes, and if so, precisely how they are linked.
Tài liệu tham khảo
Haffner SM, Stern MP, Dunn J, Mobley M, Blackwell J, Bergman RN: Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans. Metabolism: Clinical and Experimental. 1990, 39: 842-847.
Hofso D, Jenssen T, Bollerslev J, Roislien J, Hager H, Hjelmesaeth J: Anthropometric characteristics and type 2 diabetes in extremely obese Caucasian subjects: a cross-sectional study. Diabetes Research and Clinical Practice. 2009, 86: e9-11. 10.1016/j.diabres.2009.06.016.
Ferrannini E, Smith JD, Cobelli C, Toffolo G, Pilo A, DeFronzo RA: Effect of insulin on the distribution and disposition of glucose in man. Journal of Clinical Investigation. 1985, 76: 357-364. 10.1172/JCI111969.
Volpi E, Nazemi R, Fujita S: Muscle tissue changes with aging. Current Opinion in Clinical Nutrition & Metabolic Care. 2004, 7: 405-410.
Atlantis E, Martin SA, Haren MT, Taylor AW, Wittert GA, Members of the Florey Adelaide Male Ageing Study: Inverse associations between muscle mass, strength, and the metabolic syndrome. Metabolism: Clinical and Experimental. 2009, 58: 1013-1022.
Kuk JL, Kilpatrick K, Davidson LE, Hudson R, Ross R: Whole-body skeletal muscle mass is not related to glucose tolerance or insulin sensitivity in overweight and obese men and women. Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition et Metabolisme. 2008, 33: 769-774. 10.1139/H08-060.
Schutte JE, Longhurst JC, Gaffney FA, Bastian BC, Blomqvist CG: Total plasma creatinine: an accurate measure of total striated muscle mass. Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology. 1981, 51: 762-766.
Proctor DN, O'Brien PC, Atkinson EJ, Nair KS: Comparison of techniques to estimate total body skeletal muscle mass in people of different age groups. American Journal of Physiology. 1999, 277: t-95-
Yonemura K, Takahira R, Yonekawa O, Wada N, Hishida A: The diagnostic value of serum concentrations of 2-(alpha-mannopyranosyl)-L-tryptophan for normal renal function. Kidney International. 2004, 65: 1395-1399. 10.1111/j.1523-1755.2004.00521.x.
Harita N, Hayashi T, Sato KK, Nakamura Y, Yoneda T, Endo G: Lower serum creatinine is a new risk factor of type 2 diabetes: the Kansai healthcare study. Diabetes Care. 2009, 32: 424-426. 10.2337/dc08-1265.
Tomaszewski M, Charchar FJ, Maric C, McClure J, Crawford L, Grzeszczak W: Glomerular hyperfiltration: a new marker of metabolic risk. Kidney International. 2007, 71: 816-821. 10.1038/sj.ki.5002160.
Lorenzo C, Nath SD, Hanley AJ, Abboud HE, Gelfond JA, Haffner SM: Risk of type 2 diabetes among individuals with high and low glomerular filtration rates. Diabetologia. 2009, 52: 1290-1297. 10.1007/s00125-009-1361-4.
Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U: Glomerular hemodynamics in severe obesity. American Journal of Physiology - Renal Physiology. 2000, 278: F817-F822.
Griffin KA, Kramer H, Bidani AK: Adverse renal consequences of obesity. American Journal of Physiology - Renal Physiology. 2008, 294: F685-F696. 10.1152/ajprenal.00324.2007.
Hjelmesaeth J, Hofso D, Aasheim ET, Jenssen T, Moan J, Hager H: Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovascular Diabetology. 2009, diabetol..: 8
Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW: Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clinical Chemistry. 2007, 53: 766-772. 10.1373/clinchem.2006.077180.
World Medical Association declaration of Helsinki: Recommendations guiding physicians in biomedical research involving human subjects. JAMA. 1997, 277: 925-926. 10.1001/jama.277.11.925.
American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008, 31 (Suppl-60):
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.
Muniyappa R, Lee S, Chen H, Quon MJ: Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. American Journal of Physiology - Endocrinology and Metabolism. 2008, 294: E15-E26. 10.1152/ajpendo.00645.2007.
Janmahasatian S, Duffull SB, Ash S, Ward LC, Byrne NM, Green B: Quantification of lean bodyweight. Clinical Pharmacokinetics. 2005, 44: 1051-1065. 10.2165/00003088-200544100-00004.
Demirovic JA, Pai AB, Pai MP: Estimation of creatinine clearance in morbidly obese patients. American Journal of Health-System Pharmacy. 2009, 66: 642-648. 10.2146/ajhp080200.
de Jong PE, Curhan GC: Screening, monitoring, and treatment of albuminuria: Public health perspectives. Journal of the American Society of Nephrology. 2006, 17: 2120-2126. 10.1681/ASN.2006010097.
Kurtze N, Rangul V, Hustvedt BE, Flanders WD: Reliability and validity of self-reported physical activity in the Nord-Trondelag Health Study (HUNT 2). European Journal of Epidemiology. 2007, 22: 379-387. 10.1007/s10654-007-9110-9.
Wood SN: Generalized Additive Models: An Introduction with R. 2006, Boca Raton, FL: Chapman & Hall/CRC
Muggeo VM: Estimating regression models with unknown break-points. Statistics in Medicine. 2003, 22: 3055-3071. 10.1002/sim.1545.
Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL: Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Archives of Internal Medicine. 1999, 159: 2151-2159. 10.1001/archinte.159.18.2151.
Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Laakso M: Microalbuminuria precedes the development of NIDDM. Diabetes. 1994, 43: 552-557. 10.2337/diabetes.43.4.552.
Wang Z, Hoy WE: Albuminuria as a marker of the risk of developing type 2 diabetes in non-diabetic Aboriginal Australians. International Journal of Epidemiology. 2006, 35: 1331-1335. 10.1093/ije/dyl115.
R Development Core Team: R: A Language and Environment for Statistical Computing. 2008, Vienna: R Foundation for Statistical Computing
Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, Mitch WE: Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. New England Journal of Medicine. 1996, 335: 1636-1642.
Jin Y, Moriya T, Tanaka K, Matsubara M, Fujita Y: Glomerular hyperfiltration in non-proteinuric and non-hypertensive Japanese type 2 diabetic patients. Diabetes Research and Clinical Practice. 2006, 71: 264-271. 10.1016/j.diabres.2005.06.014.
Hofso D, Jenssen T, Hager H, Roislien J, Hjelmesaeth J: Fasting plasma glucose in the screening for type 2 diabetes in morbidly obese subjects. Obes Surg. 2010, 20: 302-307. 10.1007/s11695-009-0022-5.
Volpi E, Nazemi R, Fujita S: Muscle tissue changes with aging. Current Opinion in Clinical Nutrition & Metabolic Care. 2004, 7: 405-410.
Biomarkers Definitions Working Group: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clinical Pharmacology and Therapeutics. 2001, 69: 89-95. 10.1067/mcp.2001.113989.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6823/10/6/prepub